Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

JPMorgan, Goldman Sachs delay workers' return to U.K. offices

Wed, 16th Jun 2021 21:39

By Elizabeth Dilts Marshall

NEW YORK, June 16 (Reuters) - Global banks JPMorgan Chase &
Co and Goldman Sachs are delaying plans for workers to return to
U.K. offices after the government extended its COVID-19
restrictions until mid-July due to the rapid spread of the more
infectious Delta variant.

Goldman Sachs Group Inc, which required most U.S.
staff to return to offices this week, told U.K. staff on Tuesday
that working at its London office will remain voluntary for now,
according to a memo seen by Reuters. Social distancing and
mask-wearing is required, while the broader return to office
plans are postponed until July, the bank said.

JPMorgan Chase & Co, which is requiring the majority
of U.S. staff to return next month, notified U.K.-based
employees that its broad return-to-office plans are on hold
until July, according a memo to its staff.

The investment banks had planned to bring more staff back to
offices--on a rotational basis, subject to a 50% occupancy
cap--on some of the quickest timelines.

For both banks, roughly 20-30% of staff had been working in
offices for several months, which allowed them to work out
social distancing and health check protocols.

But the U.K. said delaying full reopening until July 19 will
allow it to get more people fully vaccinated. Currently, about
41 million people have received their first shot and nearly 30
million have had both doses - about 57% of the adult population.

The majority of Goldman Sachs employees have "either had
their first dose (of the vaccine) or expect to receive it before
Monday, 21 June," Richard Gnodde, head of Goldman Sachs
International, wrote in his memo to staff.

Studies on Monday showed the Delta variant doubles the risk
of hospitalization, but two doses of vaccines made by Pfizer and
AstraZeneca offer more than 90% protection against
hospitalization.
(Reporting by Elizabeth Dilts Marshall; editing by Diane Craft)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.